Windtree Therapeutics, Inc. (NasdaqCM: WINT) showcased encouraging results from the Phase 2b SEISMiC study of istaroxime, its novel investigational therapy for early cardiogenic shock, at the ...

We are investigating the physiology of CatSper Ca2+ channels, sNHE Na+/H+ exchangers, Slo3 K+ channels, Hv1 voltage-gated H+ channels, and the plasma membrane Ca2+-ATPase PMCA4. In particular, we want ...

1 Brain and Mind Research Institute, University of Sydney, Sydney, New South Wales, Australia 2 Neuroscience Research Australia & Prince of Wales Clinical School, University of New South Wales, ...